Ads
related to: health, postpartum depression- FAQs
Get Answers to Commonly Asked
Questions About Depression.
- Still Depressed On Rx?
Your Antidepressant May Only Be
Partially Working. Learn More.
- Download The Brochure
Learn More About This Treatment
Download The Patient Brochure
- Patient Tools & Resources
Get Helpful Tools
And Resources.
- Doctor Conversation Guide
Ready To Talk To Your Doctor About
Your Symptoms? Download The Guide
- Helpful Videos
Watch Patient's Journey With
Depression & This Treatment
- FAQs
Search results
This is why you're more forgetful when you're pregnant
NewFolks· 1 day agoMany people are aware of the physical changes that occur during pregnancy, but they often overlook...
watchOS 11 lets you take a day off working out without losing your streak
Engadget· 3 days agoWalking stability alerts during the third trimester can also help you avoid falling issues that...
Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL...
The Herald Journal· 3 days agoThe presentation "Intervention with oral LPCN 1148 improves sarcopenia and hepatic encephalopathy (HE) in patients with cirrhosis: a 52-week phase 2 randomized clinical trial" was presented ...
Caxton Associates LP Has $2.60 Million Stock Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE)
ETF DAILY NEWS· 1 day agoCaxton Associates LP boosted its holdings in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 76.1% during the 4th quarter, according to its most recent disclosure with the Securities ...
Selma Blair Shares Health Update Amid Multiple Sclerosis Remission - E! Online
E! Online· 7 days agoSelma Blair is feeling "really well" after a years-long health battle. "I've been in remission for a...
Sage Therapeutics (NASDAQ:SAGE) Given “Neutral” Rating at Robert W. Baird
ETF DAILY NEWS· 2 days agoRobert W. Baird reissued their neutral rating on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. The firm ...
Seven Eight Capital LP Decreases Stock Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE)
ETF DAILY NEWS· 1 day agoSeven Eight Capital LP lessened its stake in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 51.0% during the 4th quarter, according to its most recent 13F filing with the SEC ...
Ads
related to: health, postpartum depression